ZD 2079
ZD 2079 is a β3-adrenoceptor agonist. ZD 2079 inhibits ob gene expression and circulating leptin levels in lean mice in vivo, and has the potential to treat obesity and type 2 diabetes.
Catalog Number | 178600-17-4 |
Alternative Name(s) | 4-[2-[[(2R)-2-Hydroxy-2-phenylethyl]amino]ethoxy]-benzeneacetic acid hydrochloride; Talibegron hydrochloride; Talibegron HCl, Talibegron hydrochloride, D-2079, ICI-D-2079, SCH-417849, ZD-2079, D2079, ICI-D2079, SCH417849, ZD2079 |
Molecular Formula | C18H21NO4.HCl |
CAS# | 178600-17-4 |
Purity | ≥99% |
Inchi | InChI=1S/C18H21NO4.ClH/c20-17(15-4-2-1-3-5-15)13-19-10-11-23-16-8-6-14(7-9-16)12-18(21)22;/h1-9,17,19-20H,10-13H2,(H,21,22);1H/t17-;/m0./s1 |
Inchi Key | KCEFVYIWOQSJCH-LMOVPXPDSA-N |
Size | Please inquire |
Supplier Page | https://www.bocsci.com/zd-2079-cas-178600-17-4-item-222086.html |